At present, supplementary prescribing for eczema is often performed by experienced dermatology nurses, supported by a dermatologist, who work in both secondary and primary care.
Given the large number of patients with atopic eczema, this guidance may have the potential for significant cost savings.
This article examines how nurse-led care for atopic eczema is developing and what the prescribing issues are.
It is believed by some that patients presenting with generalized eczema in later life should be investigated for underlying malignancy.
In cases in which bacterial superinfection impairs eczema herpeticum, systemic antibiotic treatment should also be used.
In this review, we summarise the current knowledge of the molecular pathogenesis of eczema herpeticum.
Is deficiency of interferon gamma production by allergen triggered cord blood cells a predictor of atopic eczema?
For scabies, there is sometimes confusion with eczema but nocturnal pruritus is a particularly suggestive clinical feature helping to distinguish it.
